基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抑制剂 酪氨酸蛋白激酶/信号转导子和转录活化子抑制剂(JAK/STAT) Pim 抑制剂 (5Z)-5-[[3-(TRIFLUOROMETHYL)PHENYL]METHYLENE]-2,4-THIAZOLIDINEDIONE 化合物 SMI-4a
  • 化合物 SMI-4a|T3058|TargetMol

化合物 SMI-4a|T3058|TargetMol

(Z)-SMI-4a
438190-29-5
2280 50mg 起订
495 5mg 起订
786 10mg 起订
上海 更新日期:2024-12-12

TargetMol中国(陶术生物)

VIP3年
联系人:邵小姐
手机:4008200310 拨打
邮箱:marketing@tsbiochem.com

产品详情:

中文名称:
化合物 SMI-4a
英文名称:
(Z)-SMI-4a
CAS号:
438190-29-5
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
纯度规格:
99.44%
产品类别:
抑制剂
货号:
T3058

Product Introduction

Bioactivity

名称(Z)-SMI-4a
描述(Z)-SMI-4a (TCS PIM-1 4a) is a selective ATP-competitive Pim-1 kinase inhibitor with an IC50 of 21 nM.
激酶实验Scintillation Proximity Assay: Methyltransferase activity assays are performed by monitoring the incorporation of tritiumlabeled methyl group from S-adenosylmethionine (3H-SAM) to biotinylated peptide substrates using Scintillation Proximity Assay (SPA) for PRC2-EZH2 trimeric complex (EZH2:EED:SUZ12), PRC2-EZH1 pentameric complex (EZH1:EED:SUZ12:RBBP4:AEBP2), SETD7, G9a, GLP, SETDB1, SETD8, SUV420H1, SUV420H2, SUV39H2, MLL1 tetrameric complex (MLL:WDR5:RbBP5:ASH2L), PRMT1, PRMT3, PRMT5-MEP50 complex and SMYD2. The reaction buffer for SMYD2 and SMYD3 is 50 mM Tris pH 9.0, 5 mM DTT, 0.01% TritonX-100; for G9a, GLP and SUV39H2 is 25 mM potassium phosphate pH 8.0, 1 mM EDTA, 2 mM MgCl2 and 0.01% Triton X-100; and for other HMTs 20 mM Tris pH 8.0, 5 mM DTT, 0.01% TritonX-100. To stop the enzymatic reactions, 10 μL of 7.5 M guanidine hydrochloride is added, followed by 180 μL of buffer, mixed and transferred to a 384-well FlashPlate. After mixing, the reaction mixtures are incubated and the CPM counts are measured using Topcount plate reader. The CPM counts in the absence of compound for each data set are defined as 100% activity. In the absence of the enzyme, the CPM counts in each data set are defined as background (0%). IC50 values are determined using compound concentrations ranging from 100 nM to 100 μM. The IC50 values are determined using SigmaPlot software. EZH2-Y641F assays are performed using 30 nM of enzyme in 20 mM Tris pH 8, 5 mM DTT, 0.01% Triton X-100, 5 μM SAM and 1 μM of H3 (1-24) peptide (same as for the wild-type PRC2-EZH2 complex). For DNMT1, the assay is performed using hemimethylated dsDNA as a substrate. The dsDNA substrate is prepared by annealing two complementary strands (biotintlated forward strand: BGAGCCCGTAAGCCCGTTCAGGTCG and reverse strand: CGACCTGAACGGGCTTACGGGCTC), synthesized by Eurofins MWG Operon. Reaction buffer is 20 mM Tris-HCl, pH 8.0, 5 mM DTT, 0.01% Triton X-100.Methyltransferase activity assays for DOT1L is performed using Filter-plates. Reaction mixtures in 20 mM Tris-HCl, pH 8.0, 5 mM DTT, 2 mM MgCl2 and 0.01% Triton X-100 are incubated at room temperature for 1h, 100 μL 10% TCA is added, mixed and transferred to filter-plate. Plates are centrifuged at 2000 rpm for 2 min followed by 2 additional 10% TCA wash and one ethanol wash (180 μL) followed by centrifugation. Plates are dried and 100 μL MicroO is added and centrifuged. 70 μL MicroO is added and CPM are measured using Topcount plate reader.
体外活性口服SMI-4a后1小时,与对照组小鼠肿瘤相比,p70 S6K磷酸化减少,而总的p70 S6K表达不变.每天60 mg/kg SMI-4a处理两次,明显降低肿瘤尺寸,且具有良好的耐受性.
体内活性5 μM SMI-4a抑制胰腺癌和白血病细胞生长。SMI-4a降低前列腺和造血细胞中Pim靶点的磷酸化。SMI-4a引起细胞周期停滞并逆转Pim-1的抗凋亡活性。SMI-4a是Pim1的ATP竞争性抑制剂,IC50为17 nM。SMI-4a显示Pim1对一组激酶具有高选择性。SMI-4a抑制已知底物即翻译阻遏物4E-BP1的Pim-1的体外磷酸化。SMI-4a增加细胞核中p27Kip1的量。SMI-4a处理诱导MAPK通路上调。SMI-4a处理pre-T-LBL,抑制mTOR通路。
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度Ethanol : 27.3 mg/mL (100 mM)
DMSO : 65 mg/mL (237.89 mM), Sonication is recommended.
关键字cell-permeable | Pim kinases | autophosphorylation | 4E-BP1 | anticancer | (Z) SMI 4a | Pim-2 | (Z)SMI4a | Inhibitor | Pim-1 | inhibit | Pim
相关产品XL413 HCl | SGI-1776 | M-110 | Pim-1 kinase inhibitor 4 | Pim-1 kinase inhibitor 8 | CX-6258 hydrochloride | Quercetagetin | Pim-1/2 kinase inhibitor 1 | CK2/ERK8-IN-1 | XL413 hydrochloride | BRD7389 | K00135
相关库抑制剂库 | 经典已知活性库 | 抗癌活性化合物库 | 抗癌化合物库 | 已知活性化合物库 | 激酶抑制剂库 | 细胞凋亡化合物库 | 抗衰老化合物库 | 高选择性抑制剂库 | 临床前化合物库
TCS PIM-1 4a|||SMI-4a|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。

成立日期 (12年)
注册资本 566.265100万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生化试剂,分子生物学,分子砌块,生物技术服务

化合物 SMI-4a相关厂家报价

内容声明
拨打电话 立即询价